143 related articles for article (PubMed ID: 9540343)
1. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography elucidates transport system and tumor proliferation in meningiomas.
Murakami M; Imahori Y; Kimura S; Tatsuzawa K; Ohwada K; Inoue Y; Sasajima H; Mineura K
Oncol Rep; 2005 Oct; 14(4):853-9. PubMed ID: 16142342
[TBL] [Abstract][Full Text] [Related]
3. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
4. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
5. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
6. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
8. A study of vestibular schwannomas using positron emission tomography and monoclonal antibody Ki-67.
Chen JM; Houle S; Ang LC; Commins D; Allan K; Nedzelski J; Rowed D
Am J Otol; 1998 Nov; 19(6):840-5. PubMed ID: 9831165
[TBL] [Abstract][Full Text] [Related]
9. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Stanus E; Brotchi J; Hildebrand J
Cancer; 1996 Sep; 78(5):1098-106. PubMed ID: 8780549
[TBL] [Abstract][Full Text] [Related]
10. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
11. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
12. [Longitudinal analysis of glucose metabolism in recurrent meningioma].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1994 Nov; 46(11):1088-93. PubMed ID: 7873283
[TBL] [Abstract][Full Text] [Related]
13. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
14. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
Yamada M; Niwa Y; Matsuura T; Miyahara R; Ohashi A; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
Scand J Gastroenterol; 2007 May; 42(5):633-41. PubMed ID: 17454885
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
[TBL] [Abstract][Full Text] [Related]
18. Glucose and methionine uptake and proliferative activity in meningiomas.
Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
[TBL] [Abstract][Full Text] [Related]
20. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis].
Cremerius U; Striepecke E; Henn W; Weis J; Mull M; Lippitz B; Gilsbach J; Schröder JM; Zang KD; Böcking A
Nuklearmedizin; 1994 Aug; 33(4):144-9. PubMed ID: 7971289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
